Daniel A. Erlanson

Daniel A. Erlanson is the co-founder and President of Carmot Therapeutics, Inc. Using a proprietary technology called Chemotype Evolution, Carmot is addressing unmet chemical needs in drug discovery to tackle challenging therapeutic targets.